metoxsalene g.l. pharma
g.l. pharma gmbh - altre citochine e immunomodulatori - altre citochine e immunomodulatori
uvadex
therakos europe limited - metoxalene - metoxalene
oxsoralen
italfarmaco s.p.a. - metoxalene - metoxalene
metaossylen n gocce per uso orale
metapharmaka gmbh - cibo cretica d2, ferro da stiro sesquichloratum solubile d2, piper methysticum d6, cerchi in lega metallizzato d8 - gocce per uso orale - cibo cretica d2 50 mg, ferro da stiro sesquichloratum solubile d2 170 mg, piper methysticum d6 50 mg, zinco metallico d8 40 mg, excipiens per soluzione pro 1 g, corrisp. ethanolum 20 % v/v. - gemäss homöopathischem arzneimittelbild bei rheumatisch-neuralgischen schmerzen - farmaci omeopatici
metaossylen n tropfen zum einnehmen
metaossylen n buvable en gouttes
metoxsalene s.a.l.f.
s.a.l.f. spa laboratorio farmacologico - altre citochine e immunomodulatori - altre citochine e immunomodulatori
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasie dello stomaco - agenti antineoplastici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.